Orbimed Advisors Llc

Insider Reports History

Location
601 Lexington Avenue, 54 Th Floor, New York, NY
Signature
/s/ Carl L. Gordon, Member of OrbiMed Advisors LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Orbimed Advisors Llc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. 10%+ Owner Common Stock 5.6M $233M $41.53 Sep 12, 2022 Indirect
Enliven Therapeutics, Inc. Director, 10%+ Owner Common Stock 7.66M $170M $22.14 May 16, 2024 Indirect
Sionna Therapeutics, Inc. Director Common Stock 3.6M $160M $44.49 Nov 26, 2025 Indirect
Third Harmonic Bio, Inc. Director, 10%+ Owner Common Stock 5.78M $59.5M $10.30 Sep 19, 2022 Indirect
NeuroPace Inc 10%+ Owner Common Stock 3.24M $51.6M $15.94 May 14, 2025 Indirect
Prelude Therapeutics Inc Director, 10%+ Owner Common Stock 10.1M $38.2M $3.77 May 22, 2023 Indirect
Corvus Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 7.17M $29.8M $4.16 Jun 27, 2025 Indirect
89bio, Inc. 10%+ Owner Common Stock 1.83M $21.1M $11.53 Jan 26, 2022 Indirect
TELA Bio, Inc. 10%+ Owner Common Stock 2.41M $10.9M $4.54 Jul 2, 2024 Indirect
Venetian-1 Acquisition Corp. Director Common Stock 2.68M $10.7M $4.00 Nov 1, 2024 Indirect
Disc Medicine, Inc. Director Common Stock 187K $10.1M $54.11 Mar 24, 2025 Indirect
Edgewise Therapeutics, Inc. Director, 10%+ Owner Common Stock 444K $8.93M $20.13 Apr 3, 2025 Indirect
MBX Biosciences, Inc. Director, 10%+ Owner Common Stock 748K $8.11M $10.84 Feb 18, 2025 Indirect
PMV Pharmaceuticals, Inc. 10%+ Owner Common Stock 4.98M $7.56M $1.52 Oct 23, 2025 Indirect
Terns Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 756K $7.56M $10.00 Jul 16, 2024 Indirect
Verona Pharma plc Director Ordinary Shares 3.78M $7.46M $1.98 May 15, 2023 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Common Stock 1.51M $5.52M $3.65 Jan 30, 2024 Indirect
Keros Therapeutics, Inc. Director Common Stock 120K $5.26M $44.01 Aug 13, 2024 Indirect
Adicet Bio, Inc. 10%+ Owner Common Stock 4.49M $4.49M $1.00 Oct 8, 2025 Indirect
Acutus Medical, Inc. Director, 10%+ Owner Common Stock 1.68M $2.62M $1.56 Jul 19, 2021 Indirect
Passage BIO, Inc. 10%+ Owner Common Stock 6.07M $2M $0.33 Jun 26, 2025 Indirect
Arcutis Biotherapeutics, Inc. 10%+ Owner Common Stock 415K $1.47M $3.54 Jun 24, 2022 Indirect
Janux Therapeutics, Inc. Director Common Stock 231K $1.36M $5.87 Dec 29, 2021 Indirect
Homology Medicines, Inc. Director, 10%+ Owner Common Stock 2.25M $1.29M $0.57 Mar 25, 2024 By OrbiMed Private Investments VII, LP
Galecto, Inc. 10%+ Owner Common Stock 1.51M $1.13M $0.75 Aug 15, 2023 Indirect
scPharmaceuticals Inc. 10%+ Owner Common Stock 253K $1.01M $4.00 Aug 13, 2024 Indirect
Shattuck Labs, Inc. Director Common Stock 1.05M $912K $0.87 Aug 25, 2025 Indirect
ImageneBio, Inc. Director Common Stock 288K $717K $2.49 Jul 25, 2025 Indirect
Traws Pharma, Inc. 10%+ Owner Common Stock 602K $283K $0.47 Sep 16, 2024 Indirect
Repare Therapeutics Inc. Director Common Stock 96.2K $233K $2.43 Sep 7, 2021 Indirect
ALPINE IMMUNE SCIENCES, INC. Director Common Stock 0 $0 $6.33 May 18, 2024 Indirect
ARS Pharmaceuticals, Inc. Director Common Stock 0 $0 $13.00 Aug 26, 2024 Indirect
Compass Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $1.59 Apr 9, 2025 Indirect
Kinnate Biopharma Inc. Director, 10%+ Owner Common Stock 0 $0 $2.59 Apr 3, 2024 Indirect
Theseus Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 0 $0 $3.05 Feb 14, 2024 Indirect
Turnstone Biologics Corp. Director Common Stock 0 $0 $0.34 Aug 8, 2025 Indirect
Xtant Medical Holdings, Inc. 10%+ Owner Common Stock 0 $0 $0.42 Apr 10, 2025 Indirect
Upstream Bio, Inc. Director, 10%+ Owner Common Stock 4.55M Oct 15, 2024 Indirect
Shattuck Labs, Inc. Director Common Warrants (right to buy) 3.07M Aug 25, 2025 Indirect
Shattuck Labs, Inc. Director Pre-Funded Warrants (right to buy) 2.02M Aug 25, 2025 Indirect
Traws Pharma, Inc. 10%+ Owner Pre-Funded Warrant (right to buy) 96.3K Dec 29, 2024 Indirect
Traws Pharma, Inc. 10%+ Owner Series A Warrant (right to buy) 96.3K Dec 29, 2024 Indirect
ALPINE IMMUNE SCIENCES, INC. Director Warrant (Right to Buy) 0 Jan 11, 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Series A Preferred Stock 0 Jan 30, 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Series B Preferred Stock 0 Jan 30, 2024 Indirect
Corvus Pharmaceuticals, Inc. Director, 10%+ Owner Common Warrants (right to buy) 0 Jun 27, 2025 Indirect
Janux Therapeutics, Inc. Director Series A Convertible Preferred Stock 0 Jun 15, 2021 Indirect
Janux Therapeutics, Inc. Director Series B Convertible Preferred Stock 0 Jun 15, 2021 Indirect
MBX Biosciences, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Series C Convertible Preferred Stock 0 Sep 16, 2024 By OrbiMed Genesis Master Fund, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Common Stock 0 $55.00 Jul 1, 2022 Indirect
Sierra Oncology, Inc. Director, 10%+ Owner Series A Warrants 0 Jul 1, 2022 Indirect
Sierra Oncology, Inc. Director, 10%+ Owner Series B Warrants 0 Jan 26, 2022 Indirect
Sionna Therapeutics, Inc. Director Series B convertible preferred stock 0 Feb 10, 2025 Indirect
Sionna Therapeutics, Inc. Director Series C convertible preferred stock 0 Feb 10, 2025 Indirect
Third Harmonic Bio, Inc. Director, 10%+ Owner Series A-2 Preferred Stock 0 Sep 19, 2022 Indirect
Third Harmonic Bio, Inc. Director, 10%+ Owner Series A-3 Preferred Stock 0 Sep 19, 2022 Indirect
Third Harmonic Bio, Inc. Director, 10%+ Owner Series B Preferred Stock 0 Sep 19, 2022 Indirect
Tricida, Inc. Director, 10%+ Owner Common Stock 0 Nov 25, 2022 Indirect
Upstream Bio, Inc. Director, 10%+ Owner Series A redeemable convertible preferred stock 0 Oct 15, 2024 Indirect
Upstream Bio, Inc. Director, 10%+ Owner Series B redeemable convertible preferred stock 0 Oct 15, 2024 Indirect
Venetian-1 Acquisition Corp. Director Simple Agreement for Future Equity 0 Nov 1, 2024 Indirect

Insider Reports Filed by Orbimed Advisors Llc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SION Sionna Therapeutics, Inc. Nov 24, 2025 3 -$4.81M 4 Nov 26, 2025 Director
PMVP PMV Pharmaceuticals, Inc. Oct 23, 2025 1 -$1.52M 4 Oct 27, 2025 10%+ Owner
ACET Adicet Bio, Inc. Oct 8, 2025 2 $5M 4 Oct 10, 2025 10%+ Owner
PMVP PMV Pharmaceuticals, Inc. Sep 10, 2025 1 -$900K 4 Sep 12, 2025 10%+ Owner
STTK Shattuck Labs, Inc. Aug 25, 2025 6 $5.47M 4 Sep 2, 2025 Director
STTK Shattuck Labs, Inc. Aug 25, 2025 0 $0 3 Sep 2, 2025 Director
TSBX Turnstone Biologics Corp. Aug 8, 2025 1 $0 4 Aug 12, 2025 Director
IKNA ImageneBio, Inc. Jul 25, 2025 1 $208K 4 Jul 30, 2025 Director
CRVS Corvus Pharmaceuticals, Inc. Jun 27, 2025 3 $0 4 Jul 1, 2025 Director, 10%+ Owner
PASG Passage BIO, Inc. Jun 24, 2025 3 -$197K 4 Jun 26, 2025 10%+ Owner
NPCE NeuroPace Inc May 14, 2025 2 -$2.67M 4 May 16, 2025 10%+ Owner
PASG Passage BIO, Inc. Apr 24, 2025 3 -$78.7K 4 Apr 24, 2025 10%+ Owner
PASG Passage BIO, Inc. Apr 15, 2025 3 -$49.7K 4 Apr 17, 2025 10%+ Owner
XTNT Xtant Medical Holdings, Inc. Apr 10, 2025 2 -$30.7M 4 Apr 14, 2025 10%+ Owner
CMPX Compass Therapeutics, Inc. Apr 9, 2025 1 -$5.68M 4 Apr 11, 2025 Director, 10%+ Owner
EWTX Edgewise Therapeutics, Inc. Apr 3, 2025 2 $10M 4 Apr 4, 2025 Director, 10%+ Owner
IRON Disc Medicine, Inc. Mar 24, 2025 3 -$310K 4 Mar 26, 2025 Director
IRON Disc Medicine, Inc. Mar 19, 2025 9 -$2.83M 4 Mar 21, 2025 Director
IRON Disc Medicine, Inc. Mar 10, 2025 15 -$17M 4 Mar 12, 2025 Director
MBX MBX Biosciences, Inc. Feb 14, 2025 4 $2.02M 4 Feb 19, 2025 Director, 10%+ Owner
SION Sionna Therapeutics, Inc. Feb 10, 2025 4 $9.9M 4 Feb 10, 2025 Director
SION Sionna Therapeutics, Inc. Feb 6, 2025 0 $0 3 Feb 6, 2025 Director
PASG Passage BIO, Inc. Jan 10, 2025 3 -$142K 4 Jan 14, 2025 10%+ Owner
PASG Passage BIO, Inc. Jan 6, 2025 3 -$103K 4 Jan 8, 2025 10%+ Owner
TRAW Traws Pharma, Inc. Dec 29, 2024 2 $0 4 Jan 27, 2025 10%+ Owner
PASG Passage BIO, Inc. Dec 20, 2024 1 -$138K 4 Dec 26, 2024 10%+ Owner
PASG Passage BIO, Inc. Dec 9, 2024 3 -$52K 4 Dec 11, 2024 10%+ Owner
PASG Passage BIO, Inc. Dec 4, 2024 2 -$77.3K 4 Dec 6, 2024 10%+ Owner
NONE Lomond Therapeutics Holdings, Inc. Nov 1, 2024 13 $10M 4 Nov 5, 2024 Director
NONE Lomond Therapeutics Holdings, Inc. Nov 1, 2024 0 $0 3 Nov 5, 2024 Director
UPB Upstream Bio, Inc. Oct 15, 2024 8 $14M 4 Oct 17, 2024 Director, 10%+ Owner
UPB Upstream Bio, Inc. Oct 10, 2024 0 $0 3 Oct 10, 2024 Director, 10%+ Owner
PASG Passage BIO, Inc. Sep 19, 2024 1 -$27.9K 4 Sep 23, 2024 10%+ Owner
TRAW Traws Pharma, Inc. Sep 16, 2024 0 $0 3 Sep 23, 2024 10%+ Owner
PASG Passage BIO, Inc. Sep 16, 2024 3 -$147K 4 Sep 18, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 16, 2024 7 $12M 4 Sep 17, 2024 Director, 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Aug 26, 2024 1 -$1.09M 4 Aug 28, 2024 Director
SPRY ARS Pharmaceuticals, Inc. Aug 21, 2024 4 -$11.5M 4 Aug 23, 2024 Director
KROS Keros Therapeutics, Inc. Aug 13, 2024 2 -$11M 4 Aug 15, 2024 Director
SCPH scPharmaceuticals Inc. Aug 13, 2024 2 $2M 4 Aug 15, 2024 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Jul 15, 2024 6 -$562K 4 Jul 17, 2024 Director, 10%+ Owner
TELA TELA Bio, Inc. Jun 28, 2024 3 -$2.02M 4 Jul 2, 2024 10%+ Owner
IRON Disc Medicine, Inc. Jun 17, 2024 3 $3M 4 Jun 20, 2024 Director
ALPN ALPINE IMMUNE SCIENCES, INC. May 18, 2024 2 $0 4 May 20, 2024 Director
ELVN Enliven Therapeutics, Inc. May 16, 2024 2 -$22.9M 4 May 20, 2024 Director, 10%+ Owner
CRVS Corvus Pharmaceuticals, Inc. May 6, 2024 2 $2.5M 4 May 8, 2024 Director, 10%+ Owner
NPCE NeuroPace Inc May 1, 2024 3 -$409K 4 May 3, 2024 10%+ Owner
NPCE NeuroPace Inc Apr 24, 2024 1 -$25K 4 Apr 26, 2024 10%+ Owner
NPCE NeuroPace Inc Apr 19, 2024 3 -$913K 4 Apr 23, 2024 10%+ Owner
NPCE NeuroPace Inc Apr 16, 2024 3 -$238K 4 Apr 18, 2024 10%+ Owner
NPCE NeuroPace Inc Apr 11, 2024 2 -$7.03M 4 Apr 15, 2024 10%+ Owner
KNTE Kinnate Biopharma Inc. Apr 3, 2024 5 $0 4 Apr 5, 2024 Director, 10%+ Owner
TRAW Traws Pharma, Inc. Apr 1, 2024 0 $0 3/A Apr 12, 2024 Other*
TRAW Onconova Therapeutics, Inc. Apr 1, 2024 0 $0 3 Apr 3, 2024 10%+ Owner
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Feb 14, 2024 2 $0 4 Feb 14, 2024 Director, 10%+ Owner
AVBP ArriVent Biopharma, Inc. Jan 30, 2024 10 $8M 4 Jan 31, 2024 Director, 10%+ Owner
ACET Adicet Bio, Inc. Jan 25, 2024 3 $7.5M 4 Jan 26, 2024 Director, 10%+ Owner
AVBP ArriVent Biopharma, Inc. Jan 25, 2024 0 $0 3 Jan 25, 2024 Director, 10%+ Owner
EWTX Edgewise Therapeutics, Inc. Jan 23, 2024 1 $5M 4 Jan 25, 2024 Director, 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 11, 2024 2 $1.85M 4 Jan 16, 2024 Director
ALPN ALPINE IMMUNE SCIENCES, INC. Dec 27, 2023 6 -$28.7M 4 Dec 29, 2023 Director
IRON Disc Medicine, Inc. Dec 18, 2023 3 -$36.6K 4 Dec 20, 2023 Director
IRON Disc Medicine, Inc. Dec 14, 2023 3 -$24.6M 4 Dec 15, 2023 Director
IRON Disc Medicine, Inc. Dec 12, 2023 8 -$7.9M 4 Dec 14, 2023 Director
PMVP PMV Pharmaceuticals, Inc. Nov 22, 2023 1 -$196K 4 Nov 24, 2023 10%+ Owner
NPCE NeuroPace Inc Oct 2, 2023 2 -$75.4K 4 Oct 4, 2023 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Aug 29, 2023 1 $3.1M 4 Aug 31, 2023 Director
GLTO Galecto, Inc. Aug 15, 2023 3 -$617K 4 Aug 17, 2023 10%+ Owner
IKNA Ikena Oncology, Inc. Aug 4, 2023 2 $0 4/A Sep 21, 2023 Director
GLTO Galecto, Inc. Jul 31, 2023 3 -$628K 4 Aug 2, 2023 10%+ Owner
GLTO Galecto, Inc. Jul 25, 2023 3 -$114K 4 Jul 27, 2023 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 6 $5M 4 Jul 24, 2023 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Jul 17, 2023 2 $1.46M 4 Jul 19, 2023 Director, 10%+ Owner
GLTO Galecto, Inc. Jul 13, 2023 3 -$467K 4 Jul 17, 2023 10%+ Owner
ACET Adicet Bio, Inc. Jun 27, 2023 4 $1.83M 4 Jun 29, 2023 Director, 10%+ Owner
PASG Passage BIO, Inc. Jun 27, 2023 2 $1M 4 Jun 29, 2023 10%+ Owner
PRLD Prelude Therapeutics Inc May 22, 2023 1 $5M 4 May 24, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. May 17, 2023 2 $9.1K 4 May 19, 2023 Director, 10%+ Owner
VRNA Verona Pharma plc May 11, 2023 4 -$9.94M 4 May 15, 2023 Director
KNTE Kinnate Biopharma Inc. May 4, 2023 5 $4.09M 4 May 8, 2023 Director, 10%+ Owner
KNTE Kinnate Biopharma Inc. Apr 28, 2023 9 $3.67M 4 May 2, 2023 Director, 10%+ Owner
TELA TELA Bio, Inc. Apr 19, 2023 3 -$1.79M 4 Apr 21, 2023 10%+ Owner
GLTO Galecto, Inc. Apr 13, 2023 9 -$128K 4 Apr 17, 2023 10%+ Owner
GLTO Galecto, Inc. Apr 10, 2023 9 -$121K 4 Apr 12, 2023 10%+ Owner
GLTO Galecto, Inc. Apr 5, 2023 6 -$222K 4 Apr 7, 2023 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director, 10%+ Owner
KNTE Kinnate Biopharma Inc. Feb 17, 2023 2 $0 4 Feb 23, 2023 Director, 10%+ Owner
IRON Disc Medicine, Inc. Feb 15, 2023 3 $2.5M 4 Feb 17, 2023 Director, 10%+ Owner
IRON Disc Medicine, Inc. Dec 29, 2022 4 $0 4 Jan 3, 2023 Director, 10%+ Owner
IRON Disc Medicine, Inc. Dec 29, 2022 0 $0 3 Jan 3, 2023 Director, 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Dec 23, 2022 1 $1M 4 Dec 28, 2022 Director, 10%+ Owner
VRNA Verona Pharma plc Dec 22, 2022 5 -$136M 4 Dec 27, 2022 Director
SCPH scPharmaceuticals Inc. Nov 25, 2022 1 $4M 4 Nov 29, 2022 10%+ Owner
TCDA Tricida, Inc. Nov 22, 2022 3 -$2.21M 4 Nov 25, 2022 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. Nov 8, 2022 1 $1.29M 4 Nov 10, 2022 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Nov 7, 2022 1 $1M 4 Nov 9, 2022 Director, 10%+ Owner
THRD Third Harmonic Bio, Inc. Sep 19, 2022 5 $5.1M 4 Sep 21, 2022 Director, 10%+ Owner
EWTX Edgewise Therapeutics, Inc. Sep 16, 2022 1 $5M 4 Sep 16, 2022 Director, 10%+ Owner
THRD Third Harmonic Bio, Inc. Sep 14, 2022 0 $0 3 Sep 14, 2022 Director, 10%+ Owner
SWTX SpringWorks Therapeutics, Inc. Sep 12, 2022 2 -$4.92M 4 Sep 14, 2022 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Aug 16, 2022 6 $8.93M 4 Aug 18, 2022 Director, 10%+ Owner
XTNT Xtant Medical Holdings, Inc. Aug 15, 2022 2 $0 4 Aug 17, 2022 Director, 10%+ Owner
SWTX SpringWorks Therapeutics, Inc. Aug 8, 2022 2 -$10.5M 4 Aug 10, 2022 10%+ Owner
SRRA Sierra Oncology, Inc. Jul 1, 2022 6 -$108M 4 Jul 1, 2022 Director, 10%+ Owner
ARQT Arcutis Biotherapeutics, Inc. Jun 24, 2022 2 -$7.29M 4 Jun 28, 2022 10%+ Owner
IKNA Ikena Oncology, Inc. Jun 22, 2022 4 -$1.13M 4 Jun 24, 2022 Director
PMVP PMV Pharmaceuticals, Inc. May 26, 2022 1 -$418K 4 May 31, 2022 10%+ Owner
EWTX Edgewise Therapeutics, Inc. May 18, 2022 1 $995K 4 May 20, 2022 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. May 11, 2022 3 $420K 4 May 13, 2022 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. May 6, 2022 3 $197K 4 May 10, 2022 Director, 10%+ Owner
PASG Passage BIO, Inc. May 3, 2022 2 $1.02M 4 May 5, 2022 10%+ Owner
ARQT Arcutis Biotherapeutics, Inc. Apr 6, 2022 6 -$18.2M 4 Apr 8, 2022 10%+ Owner
PMVP PMV Pharmaceuticals, Inc. Mar 29, 2022 3 -$10.3M 4 Mar 31, 2022 10%+ Owner
KNTE Kinnate Biopharma Inc. Feb 11, 2022 4 $1.99M 4 Feb 15, 2022 Director
SRRA Sierra Oncology, Inc. Jan 26, 2022 6 $6.43M 4 Jan 28, 2022 Director, 10%+ Owner
ETNB 89bio, Inc. Jan 25, 2022 4 -$592K 4 Jan 27, 2022 10%+ Owner
PASG Passage BIO, Inc. Jan 20, 2022 1 $254K 4/A May 5, 2022 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Jan 19, 2022 3 $1.58M 4 Jan 21, 2022 Director, 10%+ Owner
PASG Passage BIO, Inc. Jan 14, 2022 3 $905K 4 Jan 20, 2022 10%+ Owner
PASG Passage BIO, Inc. Jan 11, 2022 3 $841K 4 Jan 13, 2022 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Jan 11, 2022 4 $443K 4 Jan 13, 2022 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Dec 29, 2021 2 -$820K 4 Dec 30, 2021 Director
JANX Janux Therapeutics, Inc. Dec 21, 2021 2 -$2.27M 4 Dec 23, 2021 Director
JANX Janux Therapeutics, Inc. Dec 16, 2021 2 -$7.5M 4 Dec 17, 2021 Director
ACET Adicet Bio, Inc. Dec 10, 2021 1 $3M 4 Dec 14, 2021 Director, 10%+ Owner
TCDA Tricida, Inc. Nov 15, 2021 2 $4M 4 Nov 17, 2021 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. Nov 4, 2021 2 $18.8M 4 Nov 8, 2021 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 12, 2021 7 $10M 4 Oct 14, 2021 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 6, 2021 0 $0 3 Oct 6, 2021 Director, 10%+ Owner
CRVS Corvus Pharmaceuticals, Inc. Sep 20, 2021 1 -$6.76M 4 Sep 22, 2021 Director, 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Sep 17, 2021 2 $9.5M 4 Sep 21, 2021 Director, 10%+ Owner
RPTX Repare Therapeutics Inc. Sep 3, 2021 4 -$275K 4 Sep 8, 2021 Director
RPTX Repare Therapeutics Inc. Aug 31, 2021 6 -$1.29M 4 Sep 2, 2021 Director
RPTX Repare Therapeutics Inc. Aug 26, 2021 6 -$616K 4 Aug 30, 2021 Director
RPTX Repare Therapeutics Inc. Aug 23, 2021 6 -$622K 4 Aug 25, 2021 Director
RPTX Repare Therapeutics Inc. Aug 17, 2021 4 -$693K 4 Aug 19, 2021 Director
XTNT Xtant Medical Holdings, Inc. Aug 15, 2021 2 $0 4 Aug 17, 2021 Director, 10%+ Owner
AFIB Acutus Medical, Inc. Jul 19, 2021 2 $15M 4 Jul 21, 2021 Director, 10%+ Owner
ELVN IMARA Inc. Jul 16, 2021 1 $10M 4/A Jul 23, 2021 Director, 10%+ Owner
SWTX SpringWorks Therapeutics, Inc. Jul 1, 2021 1 -$1.36M 4 Jul 6, 2021 10%+ Owner
SWTX SpringWorks Therapeutics, Inc. Jun 28, 2021 1 -$554K 4 Jun 30, 2021 10%+ Owner
SWTX SpringWorks Therapeutics, Inc. Jun 23, 2021 3 -$4.82M 4 Jun 25, 2021 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 15, 2021 8 $12M 4 Jun 16, 2021 Director
SWTX SpringWorks Therapeutics, Inc. Jun 10, 2021 1 -$2.63M 4 Jun 14, 2021 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 Director
SWTX SpringWorks Therapeutics, Inc. Jun 7, 2021 3 -$4.1M 4 Jun 9, 2021 10%+ Owner